{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:51:31Z","timestamp":1771260691639,"version":"3.50.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":308,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R310-2018-3711"],"award-info":[{"award-number":["R310-2018-3711"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The role of cranial vasodilation in headache pathogenesis sparks ongoing debate. Soluble guanylate cyclase is an enzyme that catalyses the conversion of guanosine triphosphate to cyclic guanosine monophosphate, leading to relaxation of vascular smooth muscle cells. Activation of this pathway might contribute to headache pathogenesis. We evaluated whether oral ingestion of riociguat, a stimulator of soluble guanylate cyclase, could elicit cranial vasodilation and headache in healthy adults. In this randomized, double-blind, placebo-controlled, two-way crossover study, we enrolled 12 healthy adults (nine females, three males; mean age 27.3 (SD 7.8) years). The participants attended two experimental sessions at a single site in Denmark (Danish Headache Center, Rigshospitalet, Denmark), receiving either a single oral dose riociguat 2.5\u2005mg or placebo. The baseline measurements included the diameter of the superficial temporal artery and the blood flow velocity of the middle cerebral artery. These measurements were repeated over a 240-minute period after ingestion. The participants recorded headache occurrence and associated features in a diary for 12\u2005h post-ingestion. For primary outcome (n = 12), results revealed no significant change in the diameter of the superficial temporal artery from baseline to 90\u2005min post-ingestion between riociguat and placebo (P = 0.54). However, significant increases in the diameter were observed at 120\u2005min (P = 0.02) and 240\u2005min (P &amp;lt; 0.01) after riociguat ingestion compared with placebo. The blood flow velocity of the middle cerebral artery decreased significantly from baseline to 240\u2005min post-riociguat ingestion, compared with placebo (P &amp;lt; 0.01). Headache was reported by 10 (83%) of 12 participants after riociguat ingestion, compared with three (25%) participants after placebo (P = 0.02). In conclusion, oral ingestion of riociguat, a stimulator of soluble guanylate cyclase, induces cranial vasodilation and headache. These findings support the hypothesis that cranial vasodilation mediated via direct soluble guanylate cyclase stimulation contributes to headache pathogenesis. Further research is warranted to delineate the relative contributions of nitric oxide-dependent versus nitric oxide-independent soluble guanylate cyclase activation, and to evaluate guanylate cyclase signalling as a potential therapeutic target in headache disorders.<\/jats:p>","DOI":"10.1093\/braincomms\/fcaf436","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:11:47Z","timestamp":1762647107000},"source":"Crossref","is-referenced-by-count":1,"title":["Soluble guanylate cyclase induces cranial vasodilation and headache in adults: a randomized trial."],"prefix":"10.1093","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8442-0947","authenticated-orcid":false,"given":"Nadja B","family":"Rasmussen","sequence":"first","affiliation":[{"name":"Department of Neurology, Danish Headache Center, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen, DK- 2600 Glostrup ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , DK-2200 Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casper E","family":"Christensen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Danish Headache Center, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen, DK- 2600 Glostrup ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e5kan","family":"Ashina","sequence":"additional","affiliation":[{"name":"Department of Neurology, Danish Headache Center, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen, DK- 2600 Glostrup ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal M","family":"Amin","sequence":"additional","affiliation":[{"name":"Department of Neurology, Danish Headache Center, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen, DK- 2600 Glostrup ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , DK-2200 Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rogelio","family":"Dom\u00ednguez-Moreno","sequence":"additional","affiliation":[{"name":"Department of Neurology, Danish Headache Center, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen, DK- 2600 Glostrup ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , DK-2200 Copenhagen ,","place":["Denmark"]},{"name":"Difficult-to-Treat Headache Clinic, Department of Neurology and Psychiatry, Instituto Nacional De Ciencias M\u00e9dicas y Nutrici\u00f3n Salvador Zubir\u00e1n , 14080 Mexico City ,","place":["Mexico"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9237-5314","authenticated-orcid":false,"given":"Jawdat","family":"Abdulla","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amager-Hvidovre Hospital , Copenhagen, DK-2650 Hvidovre ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rn","family":"Carlsen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , DK-2200 Copenhagen ,","place":["Denmark"]},{"name":"Department of Cardiology, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen, DK-2200 Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Messoud","family":"Ashina","sequence":"additional","affiliation":[{"name":"Department of Neurology, Danish Headache Center, Copenhagen University Hospital\u2014Rigshospitalet , Copenhagen, DK- 2600 Glostrup ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , DK-2200 Copenhagen ,","place":["Denmark"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"10440","key":"2025112901523949600_fcaf436-B1","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: A systematic analysis for the global burden of disease study 2021","volume":"403","author":"Ferrari","year":"2024","journal-title":"Lancet"},{"key":"2025112901523949600_fcaf436-B2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1212\/WNL.0000000000006697","article-title":"Red and orange flags for secondary headaches in clinical practice SNNOOP10 list","volume":"92","author":"Do","year":"2018","journal-title":"Neurology"},{"issue":"8","key":"2025112901523949600_fcaf436-B3","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","article-title":"Migraine and the trigeminovascular system\u201440 years and counting","volume":"18","author":"Ashina","year":"2019","journal-title":"Lancet Neurol"},{"key":"2025112901523949600_fcaf436-B4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fncel.2018.00233","article-title":"Vascular contributions to migraine: Time to revisit?","volume":"12","author":"Mason","year":"2018","journal-title":"Front Cell Neurosci"},{"issue":"19","key":"2025112901523949600_fcaf436-B5","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1056\/NEJMra1915327","article-title":"Migraine","volume":"383","author":"Ashina","year":"2020","journal-title":"N Engl J Med"},{"issue":"191","key":"2025112901523949600_fcaf436-B6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-3-540-68964-5_2","article-title":"Biochemistry of soluble guanylate cyclase","volume":"191","author":"Derbyshire","year":"2009","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"2025112901523949600_fcaf436-B7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/j.pain.0000000000002008","article-title":"Intradural artery dilation during experimentally induced migraine attacks","volume":"162","author":"Christensen","year":"2021","journal-title":"Pain"},{"issue":"5","key":"2025112901523949600_fcaf436-B8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0333102412475239","article-title":"The effect of sodium nitroprusside on cerebral hemodynamics and headache in healthy subjects","volume":"33","author":"Guo","year":"2013","journal-title":"Cephalalgia"},{"issue":"1","key":"2025112901523949600_fcaf436-B9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1468-1331.1994.tb00053.x","article-title":"A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks","volume":"1","author":"Thomsen","year":"1994","journal-title":"Eur J Neurol"},{"issue":"12","key":"2025112901523949600_fcaf436-B10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrneurol.2017.137","article-title":"Human models of migraine-short-term pain for long-term gain","volume":"13","author":"Ashina","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"2025112901523949600_fcaf436-B11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3959(89)90067-5","article-title":"Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics","volume":"38","author":"Iversen","year":"1989","journal-title":"Pain"},{"issue":"Pt 9","key":"2025112901523949600_fcaf436-B12","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/brain\/123.9.1830","article-title":"Nitric oxide-induced headache in patients with chronic tension-type headache","volume":"123","author":"Ashina","year":"2000","journal-title":"Brain"},{"issue":"8","key":"2025112901523949600_fcaf436-B13","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1177\/0333102421989617","article-title":"Comprehensive clinical phenotyping of nitroglycerin infusion induced cluster headache attacks","volume":"41","author":"Wei","year":"2021","journal-title":"Cephalalgia"},{"issue":"8","key":"2025112901523949600_fcaf436-B14","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/00001756-199308000-00008","article-title":"Nitric oxide supersensitivity: A possible molecular mechanism of migraine pain","volume":"4","author":"Olesen","year":"1993","journal-title":"Neuroreport"},{"issue":"Pt 1","key":"2025112901523949600_fcaf436-B15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/3-540-32967-6_7","article-title":"Nitric oxide and the vascular endothelium","volume":"176","author":"Moncada","year":"2006","journal-title":"Handb Exp Pharmacol"},{"issue":"10","key":"2025112901523949600_fcaf436-B16","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0166-2236(02)02254-3","article-title":"cGMP and S-nitrosylation: Two routes for modulation of neuronal excitability by NO","volume":"25","author":"Ahern","year":"2002","journal-title":"Trends Neurosci"},{"key":"2025112901523949600_fcaf436-B17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1146\/annurev-biochem-050410-100030","article-title":"Structure and regulation of soluble guanylate cyclase","volume":"81","author":"Derbyshire","year":"2012","journal-title":"Annu Rev Biochem"},{"issue":"3","key":"2025112901523949600_fcaf436-B18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1124\/pr.110.002907","article-title":"cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action","volume":"62","author":"Francis","year":"2010","journal-title":"Pharmacol Rev"},{"issue":"8","key":"2025112901523949600_fcaf436-B19","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1177\/0091270008319793","article-title":"Single-dose pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase stimulator BAY 63-2521: An ascending-dose study in healthy male volunteers","volume":"48","author":"Frey","year":"2008","journal-title":"J Clin Pharmacol"},{"issue":"9","key":"2025112901523949600_fcaf436-B20","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/0301-5629(93)90089-7","article-title":"Small arteries can be accurately studied in vivo, using high frequency ultrasound","volume":"19","author":"Nielsen","year":"1993","journal-title":"Ultrasound Med Biol"},{"key":"2025112901523949600_fcaf436-B21","volume-title":"Handbook of experimental pharmacology","author":"Sandner","year":"2018"},{"issue":"6","key":"2025112901523949600_fcaf436-B22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s40262-017-0604-7","article-title":"Clinical pharmacokinetic and pharmacodynamic profile of Riociguat","volume":"57","author":"Frey","year":"2018","journal-title":"Clin Pharmacokinet"},{"key":"2025112901523949600_fcaf436-B23","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1086\/685020","article-title":"Bioavailability, pharmacokinetics, and safety of riociguat given as an oral suspension or crushed tablet with and without food","volume":"6","author":"Saleh","year":"2016","journal-title":"Pulm Circ"},{"issue":"Suppl 1","key":"2025112901523949600_fcaf436-B24","first-page":"S27","article-title":"Absorption of riociguat (BAY 63-2521): Bioavailability, food effects, and dose proportionality","volume":"6","author":"Becker","year":"2016","journal-title":"Pulm Circ"},{"key":"2025112901523949600_fcaf436-B25","doi-asserted-by":"crossref","first-page":"136840","DOI":"10.1016\/j.neulet.2022.136840","article-title":"Soluble guanylate cyclase stimulator riociguat improves spatial memory in mice via peripheral mechanisms","volume":"788","author":"Nelissen","year":"2022","journal-title":"Neurosci Lett"},{"issue":"8","key":"2025112901523949600_fcaf436-B26","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s00213-018-4938-0","article-title":"The effects of the soluble guanylate cyclase stimulator riociguat on memory performance in healthy volunteers with a biperiden-induced memory impairment","volume":"235","author":"Borghans","year":"2018","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"2025112901523949600_fcaf436-B27","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00210-019-01779-z","article-title":"cGMP: A unique 2nd messenger molecule\u2014Recent developments in cGMP research and development","volume":"393","author":"Friebe","year":"2020","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"2025112901523949600_fcaf436-B28","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40263-020-00706-8","article-title":"Targeting BK Ca channels in migraine: Rationale and perspectives","volume":"34","author":"Al-Karagholi","year":"2020","journal-title":"CNS Drugs"},{"issue":"12","key":"2025112901523949600_fcaf436-B29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11916-020-00911-6","article-title":"Latest insights into the pathophysiology of migraine: The ATP-sensitive potassium channels","volume":"24","author":"Kokoti","year":"2020","journal-title":"Curr Pain Headache Rep"},{"issue":"2","key":"2025112901523949600_fcaf436-B30","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1152\/jn.00058.2004","article-title":"Modulation of dural nociceptor mechanosensitivity by the nitric oxide-cyclic GMP signaling cascade","volume":"92","author":"Levy","year":"2004","journal-title":"J Neurophysiol"},{"issue":"9","key":"2025112901523949600_fcaf436-B31","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41583-020-0333-z","article-title":"Emerging importance of satellite glia in nervous system function and dysfunction","volume":"21","author":"Hanani","year":"2020","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"2025112901523949600_fcaf436-B32","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/glia.23603","article-title":"Nitric oxide as a messenger between neurons and satellite glial cells in dorsal root ganglia","volume":"67","author":"Belzer","year":"2019","journal-title":"Glia"},{"issue":"3","key":"2025112901523949600_fcaf436-B33","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1006\/bbrc.1999.1444","article-title":"Tissue distribution of the human soluble guanylate cyclases","volume":"263","author":"Budworth","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2025112901523949600_fcaf436-B34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0898-6568(02)00078-5","article-title":"Major occurrence of the new \u03b12\u03b21 isoform of NO-sensitive guanylyl cyclase in brain","volume":"15","author":"Mergia","year":"2003","journal-title":"Cell Signal"},{"issue":"2","key":"2025112901523949600_fcaf436-B35","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/0333102418787336","article-title":"Sildenafil and calcitonin gene-related peptide dilate intradural arteries: A 3T MR angiography study in healthy volunteers","volume":"39","author":"Christensen","year":"2019","journal-title":"Cephalalgia"}],"container-title":["Brain Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/braincomms\/advance-article-pdf\/doi\/10.1093\/braincomms\/fcaf436\/65220903\/fcaf436.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/7\/6\/fcaf436\/65220903\/fcaf436.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/braincomms\/article-pdf\/7\/6\/fcaf436\/65220903\/fcaf436.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T06:52:47Z","timestamp":1764399167000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/braincomms\/article\/doi\/10.1093\/braincomms\/fcaf436\/8314652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/braincomms\/fcaf436","relation":{},"ISSN":["2632-1297"],"issn-type":[{"value":"2632-1297","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"fcaf436"}}